This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: National Institute of Health and Medical Research. Active years: 2010-2011.
Company Filing History:
Years Active: 2010-2011
Title: Pascale Giraudon: Innovator in Immunology and Neurology
Introduction
Pascale Giraudon is a notable inventor based in Lyons, France. He has made significant contributions to the fields of immunology and neurology through his innovative research and patented inventions. With a total of 2 patents, Giraudon is recognized for his work in developing therapies for various disorders affecting the nervous system and immune system.
Latest Patents
Giraudon's latest patents include the use of anti-CD100 antibodies for the treatment of inflammatory disorders affecting the central or peripheral nervous system. This invention focuses on the application of BD16 and/or BB18 anti-CD100 antibodies, or their chimeric or humanized forms, for the therapy or diagnosis of central nervous system disorders, particularly myelin disorders such as multiple sclerosis. Another significant patent involves the use of a protein from the CRMP family for treating diseases related to the immune system. This invention encompasses various forms of the CRMP protein, including polypeptide fragments and antibodies, aimed at producing medicines for autoimmune pathologies.
Career Highlights
Pascale Giraudon is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research and develops his inventions. His work has been instrumental in advancing therapeutic options for patients suffering from complex neurological and immune disorders.
Collaborations
Giraudon collaborates with esteemed colleagues, including Marie-Françoise Belin and Laurence Boumsell, who contribute to his research endeavors. Their combined expertise enhances the impact of their work in the scientific community.
Conclusion
Pascale Giraudon is a prominent inventor whose contributions to immunology and neurology are shaping the future of medical treatments. His innovative patents reflect a commitment to addressing critical health challenges.